Literature DB >> 15158528

Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status.

Sridevi Devaraj1, Robert S Rosenson, Ishwarlal Jialal.   

Abstract

Inflammation and hypercoagulability predispose to atherothrombosis and seem to be important features of the metabolic syndrome. The most convincing evidence is the association with increased levels of C-reactive protein. The hemostatic abnormality that has been most consistently associated with insulin resistance is an elevated plasminogen activator inhibitor-1 level. In contrast, markers of hypercoagulability have been associated inconsistently with hyperinsulinemia and glucose intolerance. Fibrinogen clusters with inflammatory factors, which suggests involvement of adipose tissue-generated inflammatory cytokines. Elevated von Willebrand's factor and factor VIII levels aggregate with indicators of endothelial injury,whereas vitamin K-dependent coagulation proteins correlate with triglyceride levels.

Entities:  

Mesh:

Year:  2004        PMID: 15158528     DOI: 10.1016/j.ecl.2004.03.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  27 in total

1.  Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents.

Authors:  C Platat; A Wagner; T Klumpp; B Schweitzer; C Simon
Journal:  Diabetologia       Date:  2006-06-22       Impact factor: 10.122

2.  CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.

Authors:  Sridevi Devaraj; Michael M Swarbrick; Uma Singh; Beverley Adams-Huet; Peter J Havel; Ishwarlal Jialal
Journal:  Am J Clin Pathol       Date:  2008-05       Impact factor: 2.493

3.  Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis.

Authors:  Monalyn Labitigan; Asena Bahče-Altuntas; Joel M Kremer; George Reed; Jeff D Greenberg; Nicole Jordan; Chaim Putterman; Anna Broder
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

4.  Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis.

Authors:  Smriti K Raychaudhuri; Sidhartha Chatterjee; Caroline Nguyen; Manpreet Kaur; Ishwarlal Jialal; Siba P Raychaudhuri
Journal:  Metab Syndr Relat Disord       Date:  2010-08       Impact factor: 1.894

5.  Metabolic syndrome and incident peripheral artery disease - the Multi-Ethnic Study of Atherosclerosis.

Authors:  Himabindu Vidula; Kiang Liu; Michael H Criqui; Moyses Szklo; Matthew Allison; Christopher Sibley; Pamela Ouyang; Russell P Tracy; Cheeling Chan; Mary M McDermott
Journal:  Atherosclerosis       Date:  2015-09-03       Impact factor: 5.162

6.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

7.  Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

Authors:  Sridevi Devaraj; David Siegel; Ishwarlal Jialal
Journal:  Am J Cardiol       Date:  2007-08-16       Impact factor: 2.778

Review 8.  Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Authors:  Sridevi Devaraj; Simona Valleggi; David Siegel; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

9.  Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.

Authors:  J-P Baillargeon; A C Carpentier
Journal:  Diabetologia       Date:  2007-09-27       Impact factor: 10.122

10.  Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women.

Authors:  F Santini; M Giannetti; S Mazzeo; P Fierabracci; G Scartabelli; A Marsili; R Valeriano; A Pucci; M Anselmino; V Zampa; P Vitti; A Pinchera
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.